Decisions of Optomed’s Extraordinary General Meeting

Optomed Plc Stock Exchange Release 6 September 2022 at 13.30, Helsinki

Decisions of Optomed’s Extraordinary General Meeting

The Extraordinary General Meeting of Optomed Plc held on 6 September 2022 has elected Mr. Mars Duan to the Board of Directors of the company. Mars Duan is independent of the company and dependent of a major shareholder.

The Board of Directors of Optomed Plc currently consists of the following persons: the Chairman Petri Salonen, Mars Duan, Seppo Mäkinen, Reijo Tauriainen and Anna Tenstam.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.

www.optomed.com